Pharmacokinetic and technical comparison of Sandostatin<sup>® </sup>LAR<sup>® </sup>and other formulations of long-acting octreotide
<p>Abstract</p> <p>Background</p> <p>Sandostatin<sup>® </sup>LAR<sup>® </sup>(Novartis Pharma AG) is a long-acting repeatable formulation of the somatostatin analogue octreotide, the safety and efficacy of which has been established through 15 ye...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-09-01
|
| Series: | BMC Research Notes |
| Online Access: | http://www.biomedcentral.com/1756-0500/4/344 |